These Hedge-Fund-Backed Companies Are Going Public — And Not Through SPACs

Hedge funds including Viking, Citadel, and Point72 are gearing up for five biopharma company IPOs.

(Michael Nagle/Bloomberg)

(Michael Nagle/Bloomberg)

SPACs aren’t the only way companies are going public.

At least five fledgling biopharma companies recently filed plans to go public via traditional initial public offerings.

Three of the companies filed their preliminary prospectus on Friday, while the other two set preliminary terms on Monday.


To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.